Trajan Group Holdings Ltd (TRJ) AI Stock Analysis

• Market Cap: AU$114.28M
• Dividend Yield: N/A
• Average Volume (3M): 45.52K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.31
• Revenue Growth: 0.70%
• EPS Growth: -1600.91%
• Country: AU
• Employees: 600
• Sector: Healthcare
• Sector Strength: 46
• Industry: Medical - Instruments & Supplies
• EPS (TTM): <0.01
• Shares Outstanding: 152,377,990
• 10 Day Avg. Volume: 82,457
• 30 Day Avg. Volume: 45,515
• PEG Ratio: -5.59
• Price to Book (P/B): 4.48
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 35.53
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: AU$1.50
• Price Target Upside: 97.37% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 45 Neutral
• Price Target: AU$0.50 ▼(-34.21%Downside)

The overall stock score for Trajan Group Holdings Ltd reflects significant financial and technical challenges. The most impactful factors are the company's declining revenues and profitability, along with bearish technical indicators. Valuation concerns further weigh on the score, with the absence of dividends and a negative P/E ratio. The company needs to address these issues to improve its market standing.

Trajan Group Holdings Ltd Business Overview & Revenue Model

Company Description

Trajan Group Holdings Limited develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. The company operates through two segments, Analytical Products and Life Science Solutions. It offers analytical products, including syringes, GC consumables, septas, caps, liners, gas filters, and tubing products; pathology solutions; and sampling products, as well as automation systems for the analysis of biological, food, and environmental samples. The company also provides nutrition testing solutions for pathology laboratories, research and clinical trials, personalized nutrition, corporate wellness, and health insurance. In addition, it offers automation workflow solutions, micro sampling devices, and data analysis services. Trajan Group Holdings Limited was incorporated in 2011 and is headquartered in Ringwood, Australia.

How the Company Makes Money

Trajan Group Holdings Ltd generates revenue primarily through the sale of its precision consumables, devices, and systems to laboratories, research institutions, and healthcare providers. The company leverages its expertise in analytical sciences to produce high-quality products that are critical in various scientific and clinical applications. Key revenue streams include direct sales to end-users, partnerships with leading research organizations, and collaborations with healthcare institutions for the integration of their products into broader clinical workflows. Additionally, Trajan Group Holdings may engage in strategic partnerships and licensing agreements that contribute to its earnings by expanding its market reach and product offerings.

Trajan Group Holdings Ltd Financial Statement Overview

Summary

Trajan Group Holdings Ltd is experiencing financial challenges, with declining revenues and profitability pressures. The balance sheet shows moderate leverage, but net losses have negatively impacted equity metrics. Cash flow generation is strained, indicating potential liquidity risks. Improvement is needed in profitability and operational stability.

Income Statement

The company experienced a decline in revenue in the most recent year, dropping from $162.2M to $155M. Gross profit margin decreased significantly from previous years, indicating cost pressures or reduced pricing power. The net profit margin turned negative, reflecting a loss position, which is concerning for profitability. The EBIT and EBITDA margins also worsened, further highlighting operational challenges.

Balance Sheet

The balance sheet shows moderate stability with a debt-to-equity ratio of 0.55 in 2024, indicating manageable leverage but a decrease from 2023. Stockholders' equity decreased, negatively affecting the equity ratio. However, the company's return on equity turned negative due to net losses, which is a notable downside.

Cash Flow

Operating cash flow showed slight stability, but the free cash flow decreased from the previous year. The operating cash flow to net income ratio suggests that cash generation is better than accounting income, which is a positive aspect. However, the overall cash flow situation is under pressure due to declining free cash flow, indicating potential liquidity risks.

Breakdown	TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	159.62M	155.02M	162.15M	107.57M	76.57M	71.85M
Gross Profit	60.24M	59.75M	22.93M	42.63M	28.48M	5.86M
EBITDA	10.95M	-20.36M	14.86M	5.14M	3.46M	3.26M
Net Income	-28.48M	-25.33M	1.89M	1.70M	1.88M	2.62M
Balance Sheet
Total Assets	199.03M	188.00M	229.04M	206.78M	99.38M	44.37M
Cash, Cash Equivalents and Short-Term Investments	10.44M	11.24M	11.04M	13.16M	51.72M	4.79M
Total Debt	55.94M	56.16M	61.30M	66.18M	17.02M	14.97M
Total Liabilities	93.36M	85.15M	99.51M	90.27M	33.30M	26.63M
Stockholders Equity	105.67M	102.85M	129.53M	116.51M	66.08M	17.74M
Cash Flow
Free Cash Flow	8.43M	6.43M	998.00K	-1.28M	8.34M	964.00K
Operating Cash Flow	11.95M	9.47M	9.55M	2.13M	9.45M	1.76M
Investing Cash Flow	-3.52M	-3.04M	-8.55M	-116.38M	402.00K	-797.00K
Financing Cash Flow	-9.99M	-6.40M	-3.36M	74.69M	36.81M	-236.00K

Trajan Group Holdings Ltd Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.76
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:TRJ, the sentiment is Negative. The current price of 0.76 is above the 20-day moving average (MA) of 0.74, below the 50-day MA of 0.80, and below the 200-day MA of 0.97, indicating a bearish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 41.84 is Neutral, neither overbought nor oversold. The STOCH value of 74.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:TRJ.

Trajan Group Holdings Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	S$1.49B	2.89	2.87%	4.98%	17.84%	20.03%
TRJ	45 Neutral	AU$114.28M	―	-24.66%	―	0.70%	-1600.91%
EMFGF		$27.75M	―	-481.21%	―	―	―
RMLRF		$1.93B	7.95	26.42%	1.20%	―	―
STGXF		$644.99M	12.39	30.57%	4.91%	―	―
RW8		€7.41B	89.66	37.44%	0.56%	―	―
BTH	55 Neutral	$176.66M	―	-33.75%	―	-11.19%	-174.51%

Trajan Group Holdings Ltd Corporate Events

Trajan Group Holdings Ltd Announces Cessation of Securities

Trajan Group Holdings Ltd has announced the cessation of 88,635 securities due to the lapse of conditional rights, as the conditions for these securities have not been met or have become incapable of being satisfied. This announcement may impact the company’s issued capital and could have implications for stakeholders regarding the company’s securities management.

The most recent analyst rating on (AU:TRJ) stock is a Buy with a A$1.20 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.

Trajan Group Holdings Navigates Geopolitical Challenges with Strategic Resilience

Trajan Group Holdings Limited has announced its operational update, highlighting its resilience and agility in navigating the shifting geopolitical landscape. Despite challenges such as new tariffs and reduced US government funding, Trajan maintains its FY25 revenue guidance, expecting growth of at least 3% over the prior year. The company is expanding its regional manufacturing capabilities to mitigate risks and enhance supply chain resilience, while also deepening relationships with global customers. Although there is some risk to achieving nEBITDA guidance due to margin performance, Trajan remains confident in its strategy and ability to manage through complexity.

The most recent analyst rating on (AU:TRJ) stock is a Buy with a A$1.20 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.

Trajan Group Director Alters Securities Holdings

Trajan Group Holdings Ltd has announced a change in the interests of its director, Tiffiny Lewin, involving the conversion of unlisted options into ordinary shares. This change, executed as part of the company’s Long Term Incentive Plan, results in Lewin holding a total of 110,504 ordinary shares and 53,022 unlisted options directly, with an unchanged indirect holding through ATMG Cycling Pty Ltd. The transaction reflects the company’s ongoing commitment to aligning director interests with shareholder value.

Trajan Group Holdings Ltd Expands Market Presence with New Securities Quotation

Trajan Group Holdings Ltd announced the quotation of 29,471 ordinary fully paid securities on the Australian Securities Exchange (ASX), following the exercise of options or conversion of other convertible securities. This move is part of the company’s strategy to enhance its market presence and liquidity, potentially benefiting its stakeholders by increasing the availability of its shares in the market.